Physiological Production and Polarized Secretion of the Amyloid β-Peptide in Epithelial Cells: A Route to the Mechanism of Alzheimer’s Disease

  • D. J. Selkoe
Part of the Research and Perspectives in Alzheimer’s Disease book series (ALZHEIMER)


Converging evidence from many laboratories has implicated altered metabolism of the amyloid β protein precursor (βAPP) and progressive deposition of its amyloid β-peptide (Aβ) fragment as an early and constant feature of the pathogenesis of Alzheimer’s disease. βAPP is a widely expressed type I integral membrane glycoprotein that undergoes processing by two principal routes: exocytic (secretory) and endocytic (reinternalization and lysosomal targeting). Either or both of these routes is capable of generating the intact Aβ fragment following cleavages by as yet unknown proteases. This leads to constitutive secretion of Aβ as a soluble peptide from a variety of neural and non-neural cells that express βAPP. One compartment in which Aβ generation appears to occur is the early endosome. Studies of βAPP trafficking in polarized epithelial cells grown in monolayer cultures suggests that Aβ is generated at least in part from βAPP molecules that traffic asymmetrically to the cell surfaces, with the major portion of Aβ being released from the basolateral surface. These and other studies of the detailed cellular mechanism for generation of Aβ should provide insights into specifically inhibiting cellular production and secretion of Aβ as a therapeutic approach toward slowing the progression of Alzheimer’s disease.


Madin Darby Canine Kidney Early Endosome Mock Cell Polarize Secretion Physiological Production 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Busciglio J, Gabuzda DH, Matsudaira P, Yankner BA (1993) Generation of ß-amyloid in the secretory pathway in neuronal and nonneuronal cells. Proc Natl Acad Sci USA 90: 2092–2096PubMedCrossRefGoogle Scholar
  2. Cai X-D, Golde TE, Younkin GS (1993) Release of excess amyloid ß protein from a mutant amyloid ß protein precursor. Science 259: 514–516PubMedCrossRefGoogle Scholar
  3. Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P, Vigo-Pelfrey C, Lieberburg I, Selkoe DJ (1992) Mutation of the ß-amyloid precursor protein in familial Alzheimer’s disease causes increased ß-protein production. Nature 360: 672–674PubMedCrossRefGoogle Scholar
  4. Citron M, Teplow DB, Schmitt FO, Selkoe DJ (1993) The N-terminus of amyloid ß-peptide is cleaved by a sequence specific proteins. Soc Neurosci Abstr 19 (1): 18Google Scholar
  5. Golde TE, Estus S, Younkin LH, Selkoe DJ, Younkin SG (1992) Processing of the amyloid protein precursor to potentially amyloidogenic carboxyl-terminal derivatives. Science 255: 728–730PubMedCrossRefGoogle Scholar
  6. Haass C, Koo EH, Mellon A, Hung AY, Selkoe DJ (1992a) Targeting of cell surface ß-amyloid precursor protein to lysosomes: Alternative processing into amyloid-bearing fragments. Nature 357: 500–503Google Scholar
  7. Haass C, Schlossmacher MG, Hung AY, Vigo-Pelfrey C, Mellon A, Ostaszewski BL, Lieber-burg I, Koo EH, Schenk D, Teplow DB, Selkoe DJ (1992b) Amyloid ß-peptide is produced by cultured cells during normal metabolism. Nature 359: 322–325PubMedCrossRefGoogle Scholar
  8. Haass C, Selkoe DJ (1993) Cellular processing of ß-amyloid precursor protein and the genesis of amyloid ß-peptide. Cell 75: 1039–1042PubMedCrossRefGoogle Scholar
  9. Haass C, Hung AY, Schlossmacher MG, Teplow DB, Selkoe DJ (1993) ß-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms. J Biol Chem 268: 3021–3024PubMedGoogle Scholar
  10. Haass C, Koo EH, Teplow DB, Selkoe DJ (1994) Polarized secretion of fl-amyloid precursor protein and amyloid ß-peptide in MDCK cells. Proc Natl Acad Sci USA 91: 1564–1568PubMedCrossRefGoogle Scholar
  11. Koo EH, Squazzo S (1994) Evidence that production and release of amyloid ß-protein involves the endocytic pathway. J Biol Chem 269: 17386–17389PubMedGoogle Scholar
  12. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 82: 4245–4249PubMedCrossRefGoogle Scholar
  13. Matlin KS, Simons K (1984) Sorting of an apical plasma membrane glycoprotein occurs before it reaches the cell surface in cultured epithelial cells. J Cell Biol 99: 2131–2139PubMedCrossRefGoogle Scholar
  14. Matter K, Hunziker W, Mellman I (1992) Basolateral sorting of LDL receptor in MDCK cells: the cytoplasmic domain contains two tyrosine-dependent targeting determinants. Cell 71: 741–753PubMedCrossRefGoogle Scholar
  15. Miller D, Potempska A, Papayannopoulos IA, Igbal K, Styles J, Kim KS, Mehta PR, Currie JR (1990) Characterization of the cerebral amyloid peptides and their precursors. J Neuropathol Exp Neurol 49: 267CrossRefGoogle Scholar
  16. Schellenberg GD, Bird TD, Wijsman EM, Orr HT, Anderson L, Nemens E, White JA, Bonnycastle L, Weber JL, Alonso ME, Potter H, Heston LH, Martin GM (1992) Genetic linkage evidence for a familial Alzheimer’s disease locus on chromosome 14. Science 258: 668–671PubMedCrossRefGoogle Scholar
  17. Selkoe DJ, Watson D, Hung AY, Teplow DB, Haass C (1993) Influence of the Aß C-terminal sequence and of a FAD mutation at ßAPP692 on the formation of amyloid ß-peptide. J Neurosci Abstr 19: 431Google Scholar
  18. Seubert P, Vigo-Pelfrey C, Esch F, Lee M, Dovey H, Davis D, Sinha S, Schlossmacher M, Whaley J, Swindlehurst C, McCormack R, Wolfert R, Selkoe D, Lieberburg I, Schenk D (1992) Isolation and quantification of soluble Alzheimer’s ß-peptide from biological fluids. Nature 359: 325–327PubMedCrossRefGoogle Scholar
  19. Seubert P, Oltersdorf T, Lee MG, Barbour R, Blomquist C, Davis DL, Bryant K, Fritz LC, Galasko D, Thal LJ, Lieberburg I, Schenk DB (1993) Secretion of ß-amyloid precursor protein cleaved at the amino-terminus of the ß-amyloid peptide. Nature 361: 260–263PubMedCrossRefGoogle Scholar
  20. Shoji M, Golde TE, Ghiso J, Cheung TT, Estus S, Shaffer LM, Cai X, McKay DM, Tintner R, Frangione B, Younkin SG (1992) Production of the Alzheimer amyloid ß protein by normal proteolytic processing. Science 258: 126–129PubMedCrossRefGoogle Scholar
  21. Yamaguchi H, Yamazaki T, Lemere CA, Frosch MP, Selkoe DJ (1992) Beta amyloid is focally deposited within the outer basement membrane in the amyloid nagiopathy of Alzheimer’s disease. Am J Pathol 141: 249–259PubMedGoogle Scholar
  22. Yamazaki H, Koo EH, Hedley-White ET, Selkoe DJ (1993) Intracellular trafficking of cell surface ßAPP in living cells. Soc Neurosci Abstr 19 (1): 396Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • D. J. Selkoe
    • 1
  1. 1.Harvard Medical SchoolBrigham and Women’s HospitalBostonUSA

Personalised recommendations